Search results
Results from the Tech24 Deals Content Network
Optimer structure with non target binding groups removed for improved Optimer performance and manufacturability. Optimer ligands are short synthetic oligonucleotide molecules composed of DNA or RNA that bind to a specific target molecule. They are engineered to bind their target molecules with affinity typically in the low nanomolar range. [1]
Optimer Pharmaceuticals, Inc. was founded in 1998 and registered in the state of Delaware. Corporate and R&D headquarters were located in San Diego, California until 2011. CEO Michael Nientse Chang founded, funded and built the company with his wife, Tessie Mary Che, who was COO from 1998 to 2011. From 2007 to 2013, Optimer Pharmaceuticals was ...
t. e. Search engine optimization ( SEO) is the process of improving the quality and quantity of website traffic to a website or a web page from search engines. [ 1][ 2] SEO targets unpaid traffic (known as "natural" or "organic" results) rather than direct traffic or paid traffic. Unpaid traffic may originate from different kinds of searches ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Optimer Pharmaceuticals (NAS: OPTR) is expected to report Q1 earnings around May 3. Here's what Wall Street wants to see: The 10-second takeaway Comparing the upcoming quarter to the prior-year ...
The student population is made up from three schools previously listed, along with students from Manchester High School. The school has programs for administrative office technology/business professionals, agricultural mechanics, automotive technology, carpentry, cosmetology, farm business management, health career and technology, information ...
Fast, secure and reliable email. Stay in touch and enjoy the ride with AOL Mail. supported web browser. Get user-friendly email with AOL Mail. Sign up now for world-class spam protection, easy ...
In the following video, Motley Fool health-care analyst David Williamson discusses Optimer's 10% jump on word that the company will look into "strategic alternatives" in the midst of its current ...